On Monday, Exact Sciences Corp (NASDAQ: EXAS) was 3.54% up from the session before settling in for the closing price of $64.69. A 52-week range for EXAS has been $38.81 – $72.83.
During the last 5-year period, the sales drop of Healthcare Sector giant was -54.24%. When this article was written, the company’s average yearly earnings per share was at 89.98%. With a float of $186.74 million, this company’s outstanding shares have now reached $189.22 million.
Let’s determine the extent of company efficiency that accounts for 7000 employees.
Exact Sciences Corp (EXAS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Exact Sciences Corp stocks. The insider ownership of Exact Sciences Corp is 1.36%, while institutional ownership is 96.25%. The most recent insider transaction that took place on Oct 24 ’25, was worth 780,000. In this transaction Director of this company sold 12,000 shares at a rate of $65.00, taking the stock ownership to the 60,759 shares. Before that another transaction happened on Oct 24 ’25, when Company’s Director proposed sale 12,000 for $65.00, making the entire transaction worth $780,000.
Exact Sciences Corp (EXAS) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.06 earnings per share (EPS) during the time that was better than consensus figure (set at -0.19) by 0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 89.98% per share during the next fiscal year.
Exact Sciences Corp (NASDAQ: EXAS) Trading Performance Indicators
You can see what Exact Sciences Corp (EXAS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.31. Likewise, its price to free cash flow for the trailing twelve months is 74.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.42, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.44 in one year’s time.
Technical Analysis of Exact Sciences Corp (EXAS)
Looking closely at Exact Sciences Corp (NASDAQ: EXAS), its last 5-days average volume was 3.01 million, which is a jump from its year-to-date volume of 2.72 million. As of the previous 9 days, the stock’s Stochastic %D was 69.57%.
During the past 100 days, Exact Sciences Corp’s (EXAS) raw stochastic average was set at 98.84%, which indicates a significant increase from 95.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.69 in the past 14 days, which was lower than the 1.79 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $56.35, while its 200-day Moving Average is $51.47. However, in the short run, Exact Sciences Corp’s stock first resistance to watch stands at $68.19. Second resistance stands at $69.39. The third major resistance level sits at $71.48. If the price goes on to break the first support level at $64.90, it is likely to go to the next support level at $62.81. Should the price break the second support level, the third support level stands at $61.61.
Exact Sciences Corp (NASDAQ: EXAS) Key Stats
There are 189,319K outstanding shares of the company, which has a market capitalization of 12.68 billion. As of now, sales total 2,759 M while income totals -1,029 M. Its latest quarter income was 811,090 K while its last quarter net income were -1,190 K.
